Kepler Capital analyst Tobias Lukesch maintained a Buy rating on Euronext NV (0QVJ – Research Report) on February 13 and set a price target of ...
15h
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback